Poly(ethylene glycol)-coated Au nanocages have been evaluated as a potential near-infrared (NIR) contrast agent for photoacoustic tomography (PAT). Previously, Au nanoshells were found to be an effective NIR contrast agent for PAT; however, Au nanocages, with their more compact sizes (<50 nm compared to >100 nm for Au nanoshells) and larger optical absorption cross-sections, should be better suited for in vivo applications. In this study, we tested Au nanocages as a contrast agent for PAT. The result suggests that Au nanocages are promising contrast agents for our applications. We also present PAT results when novel, dye-containing nanoparticles are used as contrast agents.
INTRODUCTION
Photoacoustic tomography (PAT) is a novel, hybrid, and non-ionizing imaging modality that combines the merits of both purely optical imaging and ultrasonic imaging methods. It is also highly sensitive to the optical absorption of biological tissue. PAT provides greater spatial resolution than purely optical imaging in deep regions while simultaneously overcoming the disadvantages of ultrasonic imaging regarding both biochemical contrast and speckle artifact; it can provide high spatial resolution images with optical contrast in a region up to 5.2 cm deep. 1 PAT has been successfully applied to the visualization of different structures in biological tissues and has been especially useful in imaging the cerebral cortex of small animals. [2] [3] [4] [5] [6] PAT is also suitable for monitoring the circulation of exogeneous optical contrast agents. 7, 8 Such contrast agents have been shown to improve the sensitivity and specificity of optical imaging techniques such as optical coherent tomography (OCT), fluorescence imaging, and other microscopies. 9 Still, purely optical imaging techniques cannot provide high spatial resolution in regions beyond 1 mm deep because of the strong scattering from biological tissues.
Long-circulating, optically tunable nanoparticles have recently been applied to PAT for use as contrast agents, allowing for their uptake, delivery, and excretion from a body to be monitored. The results from such monitoring could aid in the diagnosis of cancer. For example, these small (typically 60 to 400 nm diameter) particles tend to extravate and accumulate in tumor regions via a passive mechanism referred to as the "enhanced permeability and retention effect," which has been attributed to dysfunctional anatomical conditions such as localized leaky circulatory and lymphatic systems. This feature is especially helpful in brain tumor detection since healthy vessels in the brain dissuade the extravasation of such particles because of the blood-brain barrier. As a result, nanoparticles can accumulate in the vicinity of tumor vasculature and greatly enhance NIR optical contrast. In a previous study, Au nanoshells were tested as a NIR optical contrast agent in PAT. In this study, we have sought to evaluate a new class of optically tunable nanoparticles, Au nanocages, as a potential NIR contrast agent for PAT.
This work aims to tailor the optical properties of the Au nanocages for use with PAT. To this end, we have prepared Au nanocages with an average edge length of ~50 nm. Discrete dipole approximation (DDA) calculations indicate that these small, hollow Au nanostructures have a particularly large absorption cross-section, nearly 5 orders of magnitude greater than that of conventional organic dyes. 10 This feature is attractive to absorption-based imaging techniques such as PAT. Specifically, we show the feasibility of Au nanocages as an intravascular contrast agent for PAT of small animals in vivo. The vasculature of a rat's cerebral cortex was imaged, with enhanced optical contrast being observed with the use of Au nanocages.
We also tested NIR dyes-containing nanoparticles as PAT contrast agents. Cabocyanine dyes are the most widely used NIR optical probes for imaging tumors in small animals and humans. They have exceptionally high molar absorptivity (typically 10 5 M -1 cm -1 ). Among cabocyanine dyes, indocyanine green (ICG) is particularly useful because it has been proved by the U.S. Food and Drug Administration for clinic applications. It has been used in various imaging applications such as cardiac output monitoring, hepatic function study, peripheral circulation assessment and tumor detection. However, ICG has several disadvantages. First, when administered intravenously, ICG has a plasmatic halflife of 2-4 minutes and shows extensive protein binding. The short circulation time and protein binding prevent it from effective use as a fluorescent probe for optical imaging. Second, ICG is degraded in aqueous solution and the degradation is accelerated by light and heat. The degradation makes it impossible to prepare a stable ICG bio-conjugate in the aqueous media. Consequently, several ICG derivatives have been developed. These derivatives are reactive and are more stable in aqueous media. However, the toxicity and biocompatibility of these ICG derivatives have not been fully investigated.
Phosphorex, Inc. has long been developing and commercializing near-IR nanoparticles. The nanoparticles Phosphorex developed have sizes ranging from 50 nm to 500 nm. At Phosphorex, ICG and other near-IR dyes have been encapsulated in various polymer matrixes to form nano-sized particles or spheres. Here we present the PAT results using these nanopaticles as contrast agents.
METHODS AND MATERIALS
Au nanocages with an edge length of ~50 nm were prepared in a two-step process. First, Ag nanocubes were prepared by a modified polyol process. 11 6.0 mL of ethylene glycol (EG, J.T. Baker 9300-01 Lot C42B27) was added to a glass vial and heated at 152 °C for 1 hour while being stirred with a Teflon-coated magnetic stir bar at 260 rpm's. 90 µL of a 3 mM sodium sulfide (J. T. Baker 3910)-EG solution was then injected into the vial. After 8.5 minutes, 1.5 mL of a PVP (20 mg/mL, J. T. Baker, cat. no. 3910, MW = 29,000)-EG solution was injected into the vial. Immediately thereafter, 0.50 mL of a AgNO 3 (48 mg/mL, Sigma-Aldrich 209139)-EG solution was injected into the vial. A series of color changes were observed over the next 12 minutes, with the reaction being stopped by cooling the vial to room temperature after the reaction media appeared opaque, green-ochre when viewed head-on and ruddy-red when viewed from the top. Plating was observed on the vial walls. The quenched reaction media was then diluted twice its volume with acetone and the Ag nanocubes were collected by centrifugation. The Ag nanocubes were resuspended in water and washed an additional 3 times then stored in 4 mL of deionized water for future use.
The Ag nanocubes were converted into Au nanocages via the galvanic replacement reaction. 400 µL of the Ag nanocubes were dispersed in 10 mL water containing 1 mg/mL PVP in a 50 mL flask under magnetic stirring. The suspension was heated to a gentle reflux (~10 minutes). Then 5.4 mL of a 0.5 mM HAuC l4 aqueous solution was added to the flask via syringe pump at a rate of 0.75 mL/min. Upon completion of HAuCl4 solution addition, the suspension appeared dark blue. The suspension remained heated for an additional 10 minutes. Once cooled to room temperature, the sample was saturated with NaCl (to remove AgCl) then spun down. The supernatant was discarded and the sample resuspended in water. The sample was washed 6 additional times to remove PVP and NaCl. The Au nanocage optical properties were assessed using a UV-visible spectrophotometer. The resulting Au nanocages had a peak optical extinction (absorption and scattering) at ~820 nm ( Figure 1 ), a wavelength that overlaps with the optically transparent window of biological tissues and the laser employed in the PAT experiments.
The concentration of Ag nanocubes was determined by correlating atomic emission spectroscopy with SEM, with ~10 % of the anticipated Au nanocages being lost during washing. The Au nanocages were then functionalized with poly(ethylene glycol) (PEG), which has been shown to suppress immunogenic responses and thus improve blood circulation times. 12, 13 Au nanocage surfaces were functionalized with PEG by adding 1 mL of a 1mM mPEG-SH (5000 MW PEG-SH, Nektar)-water solution to a 2 nM cage suspension. The suspension was gently agitated then allowed to sit undisturbed overnight. Residual mPEG-SH was removed by centrifugation.
Dye-containing nanoparticles were obtained from Phosphorex, Inc. At Phosphorex, ICG has been encapsulated in various polymer matrixes to form ICG nanoparticles. These nanoparticles are received from Phosphorex, Inc. and tested in our PAT imaging system. The properties of these nanoparticles are listed in the above table (Table 1 ). 
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The setup for noninvasive photoacoustic tomography of rat brains is shown in Figure 2 . A Q-switched Nd:YAG laser (LS-2137/2, LOTISTII)-pumped tunable Ti:sapphire laser (LT-2211A, LOTIS TII) was employed to provide laser pulses with a FWHM < 15 ns, a pulse repetition rate of 10 Hz, and a wavelength of 804 nm. The incident energy density of the laser beam was controlled to be less than 10 mJ/cm 2 on the surface of the rat head, which is well below the ANSI limit (32 mJ/cm 2 at 804 nm). An unfocused ultrasonic transducer (V310, Panametrics) with a central frequency of 10 MHz and a -6dB bandwidth of about 70% was used to detect the ultrasound signals. The rat was fixed with a homemade mount so that its head protruded into the water tank through a hole in the tank's bottom, with a piece of polyethylene film sealing the gap between the water and the rat's head. Ultrasonic coupling gel was applied on the surface of the rat head. The photoacoustic signals detected by the ultrasonic transducer were received by an amplifier and then sent to an oscilloscope. A computer collected the digitized signals to reconstruct the distribution of optical 
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absorption in the imaging plane through a modified backprojection algorithm. 14 Sprague Dawley rats (100-150 g, Harlan Sprague Dawley, Inc., Indianapolis, Indiana) were employed for the imaging experiments. Before imaging, the hair on each rat's head was removed with hair removal lotion. A dose of 85 mg/kg Ketamine plus 15 mg/kg Xylasine was administered intramuscularly to anesthetize the rats. The subsequent anesthesia was achieved by the inhalation of a mixture of O 2 and isoflourane. The heart rate and blood oxygenation (SpO 2 ) level were monitored by a pulse oximeter. The heart rate of the animals was ~300 bpm and the SpO 2 level was >98% during the data acquisition.
The nanocages were injected into the circulatory system of the rats through the tail veins or saphenous veins. Three successive injections of nanocages were administrated, each with a dose of ~0.8 × 10 9 nanocages/g body weight. PAT scanning started immediately following each administration. After three administrations, PAT scanning was continuously performed for up to 6 hours. After data acquisition, the rat was sacrificed with an injection of concentrated pentobarbital. Open skull surgery was performed to photograph the cerebral cortex. With another animal, a single injection with a dose of ~0.8 X 10 9 nanocages/g body weight was also performed, and PAT scanning immediately followed the injection and continued for about 3 hours. For dye-containing nanoparticles, only one injection was used for all test. Time (mm)
RESULTS

Results for Au Nanocacges
PAT images of the cerebral cortex of a rat of the three successive injections are presented in Figures 3A and 3B with the same color bars. Figure 3A shows the cerebral cortex imaging before the injection of nanocages while Figure 3B is after the injection of nanocages. Compared to Figure 3A in which only intrinsic optical contrast provides the image, Figure 3B , acquired after the administration of Au nanocages, shows the brain vasculature with much greater clarity. With Au nanocages, the optical absorption of the blood was increased and the contrast between the vessels and the background brain tissues was enhanced. All the PAT images of the rat brain match well with the open-skull anatomical photograph shown in Figure 3C .
The absorption spectrum of the nanocages mixed with rat blood was also measured ex vivo by detecting photoacoustic signals. First, nanocages were mixed with rat blood at a ratio equivalent to ~0.8 × 10 9 nanocages/g body weight, and injected into a small Tygon tube (0.94 mm OD, 51 mm ID). The tube was then illuminated by the laser while the generated photoacoustic signals were detected with a ultrasonic transducer. The laser wavelength was tuned from 764 nm to 824 nm, and the photoacoustic signals were collected. As a reference, the absorption spectrum for pure rat blood was also measured. This result is shown in Figure 4A . Figure 4A shows that with blood only, the amplitudes of measured photoacoustic signals are considerably lower. After adding the Au nanocages into the blood, the amplitudes increase by 85-106% over this wavelength range. The increases in optical absorption in vivo were also calculated for all PAT images. Figure 4B shows the enhancement result for a single injection. In Figure 4B , the enhancements have a peak value of 35 %, which occurs about 2 hours after the injection. Laser Wavelength (nm) 400 600 800 1000 1200
Laser Wavelength (nm)
To further compare Au nanoshells and Au nanocages, we simulated the extinction spectra for both nanoparticles in water using the DDA approach. with a wall thickness of 4 nm for the Au nanocages. These dimensions are similar to those materials used in the previous 7 and current work. The DDA results are shown in Figure 5 . Overall, Au nanoshells have a much greater extinction value than Au nanocages; however, the extinction of Au nanoshells is dominated by scattering. In contrast, the extinction spectrum of the Au nanocages is dominated by absorbance. As a result, at 800 nm, Au nanocages have greater absorbance than Au nanoshells (0.036 vs. 0.027 µm 2 ). Since PAT is an absorption-based technique, the greater absorption of the Au nanocages makes them more suitable than Au nanoshells for use as a contrast agent, as demonstrated in this study Another feature showed by this result is that Au nanocages have much narrower absorbance peak than Au nanoshells, and therefore more sensitive to laser wavelength.
Results for dye-containing Nanoparticles
The results for NIRex TM -4002 are shown in Figure 6 . Two PAT images of the cerebral cortex of a rat are presented in Figures 6A and 6B . Figure 6A shows the cerebral cortex imaging before the injection of nanoparticles while Figure 6B is the image after the injection of nanoparticles. Compared with Figure 6A in which only intrinsic optical contrast Figure 5 Extinction spectra calculated using Mie theory and the discrete dipole approximation (DDA) method for (A) a Au nanoshell composed of a SiO 2 core (diameter = 125 nm) and 10-nm thick Au shell and (B) a Au nanocage with an edge length of 50 nm and wall thickness of 4 nm, respectively. Both were simulated to be in a water environment. Time (mm)
provides the image, Figure 6B , acquired after the administration of Au nanocages, shows the brain vasculature with greater clarity. With nanoparticles, the optical absorption of the blood was increased and the contrast between the vessels and the background brain tissues was enhanced. A differential image is shown in Figure 6C and was obtained by subtracting the amplitude of the pre-injection image ( Figure 6A ) from that of the post-injection image ( Figure 6B ). This image displays the distribution of differential optical absorption in the rat brain as induced by the exogenous contrast agent. The increases in optical absorption after nanopariticle injection were calculated. The signals were integrated over each image and then normalized to the signal integration of the reference image. The result is shown in Figure 6C . The enhancement reaches about 50% after injection, and maintained for over 3 hour. The experiment was terminated because the unstable condition of the animal. Testing results for NIRex TM -4004 is shown in Figure 7 . These results are similar to that in Figure 6 , but only the enhancement reaches about 25% after injection, and reduced after that due to the clearance of nanopaticles from blood. 
SUMMARY
We have shown that Au nanocages and NIR dye-containing nanoparticles can be used in photoacoustic imaging to enhance the contrast between the blood vessels and the surrounding tissues. The enhanced contrast could allow more detailed vascular structures to be imaged at greater depths. Our results demonstrate that these nanoparticles are suitable contrast agents for imaging techniques based on optical absorption and in particular PAT. We envision that photoacoustic-based imaging using bioconjugated nanoparticles to target cancer cells could provide a new tool for tumor detection. 
